JPWO2021090062A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021090062A5 JPWO2021090062A5 JP2022525715A JP2022525715A JPWO2021090062A5 JP WO2021090062 A5 JPWO2021090062 A5 JP WO2021090062A5 JP 2022525715 A JP2022525715 A JP 2022525715A JP 2022525715 A JP2022525715 A JP 2022525715A JP WO2021090062 A5 JPWO2021090062 A5 JP WO2021090062A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- cancer
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962932373P | 2019-11-07 | 2019-11-07 | |
| US62/932,373 | 2019-11-07 | ||
| PCT/IB2020/000917 WO2021090062A1 (en) | 2019-11-07 | 2020-11-06 | Anti-mesothelin eribulin antibody-drug conjugates and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023500875A JP2023500875A (ja) | 2023-01-11 |
| JPWO2021090062A5 true JPWO2021090062A5 (es) | 2023-11-08 |
Family
ID=73943294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525715A Pending JP2023500875A (ja) | 2019-11-07 | 2020-11-06 | 抗メソテリンエリブリン抗体－薬物コンジュゲート及び使用方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11572414B2 (es) |
| EP (1) | EP4055053A1 (es) |
| JP (1) | JP2023500875A (es) |
| KR (1) | KR20220095197A (es) |
| CN (1) | CN114729042A (es) |
| AU (1) | AU2020380603A1 (es) |
| BR (1) | BR112022008756A2 (es) |
| CA (1) | CA3159541A1 (es) |
| CO (1) | CO2022007924A2 (es) |
| IL (1) | IL291643A (es) |
| JO (1) | JOP20220070A1 (es) |
| MX (1) | MX2022005221A (es) |
| PE (1) | PE20230467A1 (es) |
| TW (1) | TW202132345A (es) |
| WO (1) | WO2021090062A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020024551A2 (pt) | 2018-06-01 | 2021-03-02 | Eisai R&D Management Co., Ltd. | métodos para usar moduladores de splicing |
| MX2022005221A (es) | 2019-11-07 | 2022-06-08 | Eisai R&D Man Co Ltd | Conjugados de anticuerpo y farmaco de eribulina anti-mesotelina y metodos de uso. |
| KR20230020441A (ko) | 2020-06-05 | 2023-02-10 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 항-bcma 항체-약물 컨쥬게이트 및 이용 방법 |
| AU2022316425A1 (en) * | 2021-07-22 | 2024-02-01 | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Drug conjugate of eribulin derivative |
| EP4385522A1 (en) * | 2021-08-13 | 2024-06-19 | Kunshan Xinyunda Biotech Co., Ltd. | Microtubule inhibitor-based antibody-drug conjugate |
| TW202321296A (zh) | 2021-10-06 | 2023-06-01 | 美商鏈接免疫療法公司 | 抗間皮素抗原結合分子及其用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4880078A (en) | 1987-06-29 | 1989-11-14 | Honda Giken Kogyo Kabushiki Kaisha | Exhaust muffler |
| EP0368684B2 (en) | 1988-11-11 | 2004-09-29 | Medical Research Council | Cloning immunoglobulin variable domain sequences. |
| JPH06507404A (ja) | 1991-05-01 | 1994-08-25 | ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン | 感染性の呼吸性疾患の治療方法 |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US6019968A (en) | 1995-04-14 | 2000-02-01 | Inhale Therapeutic Systems, Inc. | Dispersible antibody compositions and methods for their preparation and use |
| DK0885002T3 (da) | 1996-03-04 | 2011-08-22 | Penn State Res Found | Materialer og fremgangsmåder til forøgelse af cellulær internalisering |
| US5855913A (en) | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
| US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US5874064A (en) | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| WO1998031346A1 (en) | 1997-01-16 | 1998-07-23 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
| US6653341B1 (en) | 1998-06-17 | 2003-11-25 | Eisai Co., Ltd. | Methods and compositions for use in treating cancer |
| WO1999065894A1 (en) | 1998-06-17 | 1999-12-23 | Eisai Co., Ltd. | Macrocyclic analogs and methods of their use and preparation |
| JP2002518432A (ja) | 1998-06-24 | 2002-06-25 | アドバンスト インハレーション リサーチ，インコーポレイテッド | 吸入器から放出される大多孔性粒子 |
| EP3795591B1 (en) | 2015-06-19 | 2023-09-27 | Eisai R&D Management Co., Ltd. | Cys80 conjugated immunoglobulins |
| NZ742916A (en) | 2015-12-18 | 2023-03-31 | Eisai R&D Man Co Ltd | C-terminal lysine conjugated immunoglobulins |
| WO2017136769A1 (en) | 2016-02-04 | 2017-08-10 | Eisai R&D Management Co., Ltd. | Peptide drug conjugates |
| CN114272389B (zh) | 2016-03-02 | 2023-04-18 | 卫材研究发展管理有限公司 | 基于艾日布林的抗体-药物偶联物和使用方法 |
| EP3801632A1 (en) | 2018-06-01 | 2021-04-14 | Eisai R&D Management Co., Ltd. | Splicing modulator antibody-drug conjugates and methods of use |
| CN113271981A (zh) | 2018-12-13 | 2021-08-17 | 卫材R&D管理有限公司 | 荷伯希二烯抗体-药物缀合物及使用方法 |
| MX2022005221A (es) | 2019-11-07 | 2022-06-08 | Eisai R&D Man Co Ltd | Conjugados de anticuerpo y farmaco de eribulina anti-mesotelina y metodos de uso. |
| KR20220130160A (ko) | 2020-01-22 | 2022-09-26 | 상하이 센후이 메디슨 컴퍼니 리미티드 | 에리불린 유도체의 약물 접합체, 이를 제조하기 위한 방법 및 의료분야에서 이의 용도 |
| KR20230020441A (ko) | 2020-06-05 | 2023-02-10 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 항-bcma 항체-약물 컨쥬게이트 및 이용 방법 |
-
2020
- 2020-11-06 MX MX2022005221A patent/MX2022005221A/es unknown
- 2020-11-06 BR BR112022008756A patent/BR112022008756A2/pt active Search and Examination
- 2020-11-06 CN CN202080076659.9A patent/CN114729042A/zh active Pending
- 2020-11-06 EP EP20828836.5A patent/EP4055053A1/en active Pending
- 2020-11-06 KR KR1020227016852A patent/KR20220095197A/ko unknown
- 2020-11-06 JP JP2022525715A patent/JP2023500875A/ja active Pending
- 2020-11-06 WO PCT/IB2020/000917 patent/WO2021090062A1/en active Application Filing
- 2020-11-06 TW TW109138938A patent/TW202132345A/zh unknown
- 2020-11-06 US US17/091,819 patent/US11572414B2/en active Active
- 2020-11-06 JO JOP/2022/0070A patent/JOP20220070A1/ar unknown
- 2020-11-06 AU AU2020380603A patent/AU2020380603A1/en active Pending
- 2020-11-06 CA CA3159541A patent/CA3159541A1/en active Pending
- 2020-11-06 PE PE2022000738A patent/PE20230467A1/es unknown
-
2022
- 2022-03-23 IL IL291643A patent/IL291643A/en unknown
- 2022-06-03 CO CONC2022/0007924A patent/CO2022007924A2/es unknown
- 2022-12-23 US US18/146,246 patent/US20230212310A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6333882B2 (ja) | 抗体−薬剤コンジュゲート | |
| JP2020019787A5 (es) | ||
| RU2018134331A (ru) | Конъюгаты антитело-лекарственное средство на основе эрибулина и способы применения | |
| JP2019535731A5 (es) | ||
| WO2009100194A2 (en) | Camptothecin-binding moiety conjugates | |
| US20200188525A1 (en) | Anti-egfr antibody drug conjugates (adc) and uses thereof | |
| JPWO2021090062A5 (es) | ||
| WO2006116001A2 (en) | Antibodies for the treatment of cancers | |
| US20200297863A1 (en) | Anti-egfr antibody drug conjugates (adc) and uses thereof | |
| JPWO2021251459A5 (es) | ||
| WO2023124963A1 (zh) | 一种可逆反应减少的抗体-药物偶联物，其制备方法及应用 | |
| WO2023098691A1 (zh) | 抗体药物偶联物及其用途 | |
| RU2020136692A (ru) | Конъюгаты антител с лекарственными веществами и их применение для лечения раковых заболеваний | |
| NZ744808B2 (en) | Eribulin-based antibody-drug conjugates and methods of use | |
| NZ615308B2 (en) | Antibody-drug conjugates |